The drug education presentation is set for Wednesday, Feb. 4 in New Lenox.

Although JAK2 inhibitors are a mainstay of therapy for patients with myelofibrosis, novel drug combinations and monotherapies are currently being studied in clinical trials that potentially represent ...

4 IDEAYA/GSK presentations of IDE275 (GSK959) and 4 additional presentations across IDE397/MAT2A, IDE161/PARG, PRMT5, and KAT6/7 programs at AACR 2025 IDE275 (GSK959) has demonstrated a potential best ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

What does a quantum leap in drug development look like and what is necessary to make it happen? Our greatest opportunity to deliver significant increases in the speed and effectiveness of drug ...

Shares of Palisade Bio (NASDAQ:PALI) were down 8% in late morning trading Wednesday after jumping in pre-market action around the time it announced a presentation on its ulcerative colitis drug ...

Every time Leah publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from Business ...